XML 48 R36.htm IDEA: XBRL DOCUMENT v3.25.1
EQUITY-BASED COMPENSATION (Tables)
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount The Company’s equity-based compensation expense, included within selling, general and administrative expenses in the condensed consolidated statements of operations and comprehensive income, was as follows (in thousands):
Three Months Ended March 31,
20252024
Restricted Stock$11,185 $7,303 
SARs126 162 
Total$11,311 $7,465 
Schedule of Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity A summary of Restricted Stock activity during the three months ended March 31, 2025 is as follows:
Restricted Stock
Weighted Average Grant Date
Fair Value Per Share
Outstanding as of December 31, 2024158,665$660.77 
Granted119,344$401.26 
Forfeited(7,859)$588.25 
Vested and issued(19,481)$909.97 
Outstanding as of March 31, 2025250,669$520.12 
Vested and deferred as of March 31, 20257,680$809.38 
Schedule of Share-Based Payment Award, Restricted Stock Valuation Assumptions
The significant inputs and resulting weighted average grant date fair value for market-based award grants were as follows:
20252024
Risk-free interest rate4.2 %4.0 %
Expected volatility40.6 %35.4 %
Simulation term2.99 years2.99 years
Weighted average grant date fair value$417.46$603.73
Schedule of Share-Based Payment Arrangement, Stock Appreciation Right, Activity A summary of SARs activity during the three months ended March 31, 2025 is as follows:
Stock Appreciation Rights
Weighted Average Exercise Price
Weighted Average Grant Date
Fair Value
Aggregate Intrinsic Value
(in thousands)
Weighted Average
Remaining Contractual Term
(in years)
Outstanding as of December 31, 202428,366$1,028.73 $253.47 $— 3.94
Expired(750)$1,274.05 $280.58 
Outstanding as of March 31, 202527,616$1,022.07 $252.74 $— 3.67
Exercisable as of March 31, 202526,616$990.07 $243.08 $— 3.57